billS4110Event Tuesday, March 17, 2026Analyzed

A bill to revise and extend health workforce programs under title VII of the Public Health Service Act.

Neutral

Summary

S.4110 is an early-stage authorization bill reauthorizing health workforce programs under the Public Health Service Act. It authorizes funding levels for FY2026-2030, but actual spending requires a separate appropriations process. The bill has no direct corporate beneficiaries and no market impact at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S.4110 is a procedural authorization bill reauthorizing health workforce programs with modest funding increases.
  • 2.No actual money is allocated—spending requires separate appropriations bills.
  • 3.No publicly traded companies are direct beneficiaries; the bill primarily impacts non-profit academic institutions.
  • 4.The bill is in early legislative stages with minimal momentum and no market impact.

Market Implications

No market implications at this time. The bill is an early-stage authorization affecting non-profit academic health centers, not publicly traded companies. No stock-level impact is anticipated unless the bill advances with amendments adding corporate beneficiaries or direct procurement provisions.

Full Analysis

  1. WHAT HAPPENED: On March 17, 2026, Senator Reed (D-RI) introduced S.4110, the 'EMPOWER for Health Act,' to reauthorize and incrementally increase funding for health professions workforce programs under Title VII of the Public Health Service Act. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions. It has one cosponsor (Senator Murkowski, R-AK) and is in the earliest legislative stage. 2) THE MONEY TRAIL: This is an authorization bill, not an appropriations bill. It sets maximum funding levels for FY2026-2030 for specific programs (e.g., Section 736(i) authorizes $28.422M/year for health professions education; Section 740(a) authorizes $55.014M/year for scholarships). These are ceiling amounts. No actual money is allocated—separate appropriations bills must be passed each year. The total authorized amounts across all sections sum to approximately $265M annually, a modest increase over the previous FY2021-2025 authorization levels. 3) STRUCTURAL WINNERS AND LOSERS: The funding flows to academic health centers, teaching hospitals, and health professions schools via grants. No publicly traded company is a direct beneficiary. For-profit healthcare education companies (e.g., $ATGE, $LOPE, $STRA) are not referenced in the bill—it focuses on Title VII non-profit and public institutions. No tickers meet the causal chain threshold. 4) COMPETITIVE LANDSCAPE: The bill primarily affects grant-seeking academic institutions, not for-profit entities. Should it advance and be funded through appropriations, academic medical centers and medical schools could see incremental grant increases. However, with a single primary sponsor, one cosponsor, and early-stage status, legislative momentum is minimal. 5) TIMELINE: The bill must clear the HELP committee, pass the Senate, pass the House (no companion bill identified), and be signed into law. Even if enacted, agencies (HRSA) must implement rulemaking, and annual appropriations must pass. This is a multi-year process with no near-term market implications.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →